Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 47180 [2018-20269]
Download as PDF
<![CDATA[
47180
Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices
the committee. Oral presentations from
the public will be scheduled between
approximately 8:30 a.m. and 10:30 a.m.
on October 25, 2018. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before October
1, 2018. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by October 2, 2018.
Persons attending FDA’s advisory
committee meetings are advised that
FDA is not responsible for providing
access to electrical outlets.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact LaToya Bonner
(see FOR FURTHER INFORMATION CONTACT)
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 13, 2018.
Leslie Kux,
Associate Commissioner for Policy.
daltland on DSKBBV9HB2PROD with NOTICES
[FR Doc. 2018–20233 Filed 9–17–18; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
19:14 Sep 17, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC)/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment (CHACHSPT) has scheduled
a public meeting. Information about the
CHACHSPT can be found here: https://
www.cdc.gov/maso/facm/
facmchachspt.html. An agenda may be
requested by emailing
CHACAdvisoryComm@hrsa.gov.
DATES: November 7, 2018, 8:30 a.m.–
5:00 p.m. ET and November 8, 2018,
8:30 a.m.–3:30 p.m. ET.
ADDRESSES: This meeting will be held
in-person and by webinar and
teleconference. The address for the
meeting is DoubleTree by Hilton,
Bethesda, 8120 Wisconsin Avenue,
Bethesda, Maryland 20814.
• Adobe Connect URL link: https://
hrsa.connectsolutions.com/chac_
meeting/.
• Conference call-in number: 888–
324–9617, Passcode 9245865.
FOR FURTHER INFORMATION CONTACT:
Theresa Jumento, Chief, Policy
Development Branch, HRSA, HIV/AIDS
Bureau (HAB), Division of Policy and
Data, 5600 Fishers Lane, Room 9N156,
or by email at CHACAdvisoryComm@
hrsa.gov.
SUMMARY:
The
CHACHSPT was established under
Section 222 of the Public Health Service
(PHS) Act, [42 U.S.C. Section 217a], as
amended.
The purpose of the CHACHSPT is to
advise the Secretary of HHS, the
Director of the CDC, and the
Administrator of HRSA on the
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STD prevention and treatment
efforts. This includes, but is not limited
to, surveillance of HIV infection, viral
hepatitis, and other STDs; responses to
related emerging health needs; and
epidemiologic, behavioral, health
services, and laboratory research on
HIV/AIDS, viral hepatitis, and other
STDs. The CHACHSPT also provides
advice regarding policy issues related to
HIV/viral hepatitis/STD professional
education, patient healthcare delivery,
research and training, and prevention
services.
During the November 7–8, 2018,
meeting, the CHACHSPT will discuss
the following topics:
• CHACHSPT workgroup reports and
findings;
• updates from CDC, HRSA, and
HRSA HAB;
• strategies for serving women,
infants, children, and youth;
• agencies’ responses to the opioid
crisis; and
• telemedicine initiatives.
Agenda items are subject to change as
priorities dictate. Refer to the
CHACHSPT website for any updated
information concerning the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to CHACHSPT
should be sent by email to
CHACAdvisoryComm@hrsa.gov or by
mail to Theresa Jumento at the address
above at least 3 business days prior to
the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Theresa Jumento at the address
listed above at least 10 business days
prior to the meeting.
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–20269 Filed 9–17–18; 8:45 am]
BILLING CODE 4165–15–P
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Advisory Council on Migrant
Health
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Meeting notice.
AGENCY:
The Secretary’s National
Advisory Council on Migrant Health
(NACMH) has scheduled a public
meeting. Information about NACMH
and the agenda for this meeting can be
found on the NACMH website at:
https://bphc.hrsa.gov/quality
improvement/strategicpartnerships/
nacmh/.
SUMMARY:
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 83, Number 181 (Tuesday, September 18, 2018)]
[Notices]
[Page 47180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20269]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC)/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment (CHACHSPT) has scheduled a public meeting. Information about
the CHACHSPT can be found here: https://www.cdc.gov/maso/facm/facmchachspt.html. An agenda may be requested by emailing
[email protected].
DATES: November 7, 2018, 8:30 a.m.-5:00 p.m. ET and November 8, 2018,
8:30 a.m.-3:30 p.m. ET.
ADDRESSES: This meeting will be held in-person and by webinar and
teleconference. The address for the meeting is DoubleTree by Hilton,
Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland 20814.
Adobe Connect URL link: https://hrsa.connectsolutions.com/chac_meeting/.
Conference call-in number: 888-324-9617, Passcode 9245865.
FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Chief, Policy
Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and
Data, 5600 Fishers Lane, Room 9N156, or by email at
[email protected].
SUPPLEMENTARY INFORMATION: The CHACHSPT was established under Section
222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a],
as amended.
The purpose of the CHACHSPT is to advise the Secretary of HHS, the
Director of the CDC, and the Administrator of HRSA on the objectives,
strategies, policies, and priorities for HIV, viral hepatitis, and
other STD prevention and treatment efforts. This includes, but is not
limited to, surveillance of HIV infection, viral hepatitis, and other
STDs; responses to related emerging health needs; and epidemiologic,
behavioral, health services, and laboratory research on HIV/AIDS, viral
hepatitis, and other STDs. The CHACHSPT also provides advice regarding
policy issues related to HIV/viral hepatitis/STD professional
education, patient healthcare delivery, research and training, and
prevention services.
During the November 7-8, 2018, meeting, the CHACHSPT will discuss
the following topics:
CHACHSPT workgroup reports and findings;
updates from CDC, HRSA, and HRSA HAB;
strategies for serving women, infants, children, and
youth;
agencies' responses to the opioid crisis; and
telemedicine initiatives.
Agenda items are subject to change as priorities dictate. Refer to the
CHACHSPT website for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to CHACHSPT should be
sent by email to [email protected] or by mail to Theresa
Jumento at the address above at least 3 business days prior to the
meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Theresa Jumento at the
address listed above at least 10 business days prior to the meeting.
Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-20269 Filed 9-17-18; 8:45 am]
BILLING CODE 4165-15-P
